← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2006First marketed drug
Aug 14, 2019First NDA
Aug 14, 2019Last known activity
Jul 9, 2024
Timeline
2000s
- Jan 1, 2000
Global Alliance for TB Drug Development— Founded
2010s
- Aug 14, 2019
pretomanid— NDA Organization
Drugs by trial phase (24 distinct, 38 trials)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (47)
- NCT06481163CollaboratorPhase 2Jul 9, 2024
- NCT06058299Lead sponsorPhase 2Oct 31, 2023
- NCT05686356CollaboratorPhase 2/Phase 3Jul 28, 2023
- NCT05971602CollaboratorPhase 2Jul 26, 2023
- NCT05586230CollaboratorPhase 1Feb 28, 2023
- NCT05526911Lead sponsorPhase 1Jul 21, 2022
- NCT04865536Study chairPhase 1Feb 16, 2021
- NCT04865536Lead sponsorPhase 1Feb 16, 2021
- NCT04890535Lead sponsorPhase 1Dec 1, 2020
- NCT04890535Study chairPhase 1Dec 1, 2020
- NCT04493671Lead sponsorPhase 1Jun 8, 2020
- NCT04493671Study chairPhase 1Jun 8, 2020
- NCT04179500Study chairPhase 1Apr 30, 2020
- NCT04179500Lead sponsorPhase 1Apr 30, 2020
- NCT04309656Lead sponsorPhase 1Jan 14, 2020
Details
- Founded
- Cape Town, ZA Jan 1, 2000
- First NDA
- Aug 14, 2019
- Last known activity
- Jul 9, 2024
Designations held
- Orphan drug
- Fast track
- Priority review